The presence of a right-to-left shunt is associated with dramatic improvement after thrombolytic therapy in patients with acute ischemic stroke

Stroke

Volumn 40, Issue 1, 2009, Pages 303-305

  Kimura, Kazumi ^a   Iguchi, Yasuyuki ^a   Shibazaki, Kensaku ^a   Terasawa, Yuka ^a   Aoki, Junya ^a   Matsumoto, Noriko ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

Atrial fibrillation; Outcome; Right to left shunting; TCD; Tissue plasminogen activator

Indexed keywords

FIBRIN; TISSUE PLASMINOGEN ACTIVATOR; FIBRINOLYTIC AGENT;

ADULT; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; MALE; PRIORITY JOURNAL; SHUNTING; ACUTE DISEASE; BRAIN ARTERY; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; DOPPLER ECHOGRAPHY; DRUG EFFECT; ECHOGRAPHY; EPIDEMIOLOGY; HEART ATRIUM FIBRILLATION; HEART SEPTUM DEFECT; LETTER; METHODOLOGY; MIDDLE AGED; OCCLUSIVE CEREBROVASCULAR DISEASE; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; STATISTICS; STROKE; TREATMENT OUTCOME; VEIN THROMBOSIS;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; BRAIN ISCHEMIA; CAUSALITY; CEREBRAL ARTERIES; CEREBRAL HEMORRHAGE; FEMALE; FIBRINOLYTIC AGENTS; HEART SEPTAL DEFECTS, ATRIAL; HUMANS; INTRACRANIAL THROMBOSIS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL; VENOUS THROMBOSIS;

EID: 60549091031     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.108.521146     Document Type: Article

References (15)

1. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-pa Stroke Study Group. N Engl J Med. 1995;333:1581-1587.
2. Handke M, Harloff A, Olschewski M, Hetzel A, Geibel A. Patent foramen ovale and cryptogenic stroke in older patients. N Engl J Med. 2007;357: 2262-2268.
3. Ueno Y, Iguchi Y, Inoue T, Shibazaki K, Urabe T, Kimura K. Paradoxical brain embolism may not be uncommon-prospective study in acute ischemic stroke. J Neurol. 2007;254:763-766.
4. Mammen EF. Pathogenesis of venous thrombosis. Chest. 1992;102: 640S-644S.
5. Pennica D, Holmes WE, Kohr WJ, Harkins RN, Vehar GA, Ward CA, Bennett WF, Yelverton E, Seeburg PH, Heyneker HL, Goeddel DV, Collen D. Cloning and expression of human tissue-type plasminogen activator CDNA in E. coli. Nature. 1983;301:214-221.
6. Verstraete M, Collen D. Thrombolytic therapy in the eighties. Blood. 1986;67:1529-1541.
7. Albanese MA, Clarke WR, Adams HP Jr, Woolson RF. Ensuring reliability of outcome measures in multicenter clinical trials of treatments for acute ischemic stroke. The program developed for the Trial of Org 10172 in acute stroke treatment (TOAST). Stroke. 1994;25:1746-1751.
8. Barber PA, Hill MD, Eliasziw M, Demchuk AM, Pexman JH, Hudon ME, Tomanek A, Frayne R, Buchan AM. Imaging of the brain in acute ischaemic stroke: comparison of computed tomography and magnetic resonance diffusionweighted imaging. J Neurol Neurosurg Psychiatry. 2005;76:1528-1533.
9. Yamaguchi T, Mori E, Minematsu K, Nakagawara J, Hashi K, Saito I, Shinohara Y. Alteplase at 0.6 mg/kg for acute ischemic stroke within 3 hours of onset: Japan Alteplase Clinical Trial (J-ACT). Stroke. 2006;37:1810-1815.
10. Alexandrov AV, Demchuk AM, Felberg RA, Christou I, Barber PA, Burgin WS, Malkoff M, Wojner AW, Grotta JC. High rate of complete recanalization and dramatic clinical recovery during tPA infusion when continuously monitored with 2-mHz transcranial Doppler monitoring. Stroke. 2000;31:610-614.
11. Droste DW, Silling K, Stypmann J, Grude M, Kemeny V, Wichter T, Kuhne K, Ringelstein EB. Contrast transcranial Doppler ultrasound in the detection of right-to-left shunts: time window and threshold in microbubble numbers. Stroke. 2000;31:1640-1645.
12. Gaffney PJ, Whitaker AN. Fibrin crosslinks and lysis rates. Thromb Res. 1979;14:85-94.
13. Schwartz ML, Pizzo SV, Hill RL, McKee PA. Human factor XIII from plasma and platelets. Molecular weights, subunit structures, proteolytic activation, and cross-linking of fibrinogen and fibrin. J Biol Chem. 1973;248:1395-1407.
14. del Zoppo GJ, Poeck K, Pessin MS, Wolpert SM, Furlan AJ, Ferbert A, Alberts MJ, Zivin JA, Wechsler L, Busse O, et al. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol. 1992;32:78-86.
15. Saito T, Tamura K, Uchida D, Saito T, Nitta T, Sugisaki Y. Histopathological evaluation of left atrial appendage thrombogenesis removed during surgery for atrial fibrillation. Am Heart J. 2007;153:704-711.